Yuan Hongbin, Kozikowski Alan P, Petukhov Pavel A
Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
J Med Chem. 2004 Dec 2;47(25):6137-43. doi: 10.1021/jm049544s.
A 3D-QSAR CoMFA study of piperidine-based analogues of cocaine with flexible 3 alpha-substituents is described. A series of pharmacophore models were generated based on three representative compounds 1p, 2i, and 3c using the Genetic Algorithm Similarity Program (GASP) method. The flexible superposition of all studied compounds was performed for each pharmacophore model using the FlexS algorithm and the three-dimensional structure of 2i as a template. All sets of the overlaid structures with the top-ranked conformers were used for CoMFA modeling. Two best initial CoMFA models were selected and further optimized by identifying the best-fitting conformer of each compound. Compared with the initial models, the conventional correlation coefficients r(2) for the optimized models 1 and 2 were improved from 0.90 and 0.837 to 0.997 and 0.993, respectively. The leave-one-out cross-validated coefficients q(2) for the optimized models 1 and 2 were improved from 0.515 and 0.296 to 0.828 and 0.849, respectively. The results of the two CoMFA models suggest that both steric and electrostatic interactions play important roles in the binding of the 3 alpha-substituents of the piperidine-based analogues of cocaine. The contributions from steric and electrostatic fields for model 1 were 0.621 and 0.379, respectively. The contributions from steric and electrostatic fields for model 2 were 0.493 and 0.507, respectively. The two highly predictive CoMFA models indicate that the 3 alpha-substituent has two possible binding modes at the DAT. The CoMFA contour maps provide a visual representation of prospective binding modes of the 3 alpha-substituent of the piperidine-based analogues of cocaine and can be used to design novel DAT inhibitors that may be useful for the treatment of cocaine abuse and certain neurological disorders.
描述了对具有柔性3α-取代基的可卡因哌啶基类似物的3D-QSAR CoMFA研究。使用遗传算法相似性程序(GASP)方法,基于三种代表性化合物1p、2i和3c生成了一系列药效团模型。使用FlexS算法并以2i的三维结构为模板,对每个药效团模型进行所有研究化合物的柔性叠加。所有叠加结构与排名靠前的构象异构体的集合用于CoMFA建模。选择了两个最佳初始CoMFA模型,并通过识别每种化合物的最佳拟合构象异构体进一步优化。与初始模型相比,优化模型1和2的传统相关系数r(2)分别从0.90和0.837提高到0.997和0.993。优化模型1和2的留一法交叉验证系数q(2)分别从0.515和0.296提高到0.828和0.849。两个CoMFA模型的结果表明,空间和静电相互作用在可卡因哌啶基类似物的3α-取代基的结合中都起着重要作用。模型1中空间和静电场的贡献分别为0.621和0.379。模型2中空间和静电场的贡献分别为0.493和0.507。这两个高度预测性的CoMFA模型表明,3α-取代基在多巴胺转运体(DAT)处有两种可能的结合模式。CoMFA等高线图直观地展示了可卡因哌啶基类似物的3α-取代基的预期结合模式,可用于设计新型DAT抑制剂,这些抑制剂可能对治疗可卡因成瘾和某些神经疾病有用。